Editorial Board
Philippe Pourquier
INSERM U1194, Montpellier Cancer Research Institute, France · France
Editorial leadership for Journal of DNA And RNA Research ISSN 2575-7881
Research interests
- Following A Phd In Biochemistry
- Molecular Biology
- A Postdoctoral Stay In The Laboratory Of Molecular Pharmacology (Dr Y. Pommier) At The National Cancer Institute
- Dr Pourquier Acquired A Solid Experience In The Field Of Dna Topoisomerases
- Their Inhibitors Used In Cancer Chemotherapy. In 2001 He Obtained A Senior Investigator Position At Inserm. He Is Currently The Head Of The Molecular Pharmacology Group Of The Inserm U916 Unit At The BergoniÃ&Copy; Cancer Institute Of Bordeaux
- France. He Is Developing Basic Research Programs In The Field Of Drug Resistance To Topoisomerase Inhibitors
- Has Recently Developed Translational Research Programs To Identify Alternative Therapies For The Treatment Of Castration-Resistant Prostate Cancers
- New Markers Of Sensitivity To Anticancer Drugs That Are Used Or Developed In That Indication
Biography
- Dr Philippe Pourquier obtained a doctorate (Ph.D.) in Biochemistry and Molecular Biology from the University of Bordeaux, France.
- Dr Pourquier also holds a Pharmacy Doctorate from the same University.
- Dr Pourquier is currently a Research Director at the french National Institute of Health and Medical Research (INSERM) in the research unit U1194 in Montpellier, France.
- Dr Pourquier acquired a solid experience in the field of drug resistance to anticancer agents, in particular DNA topoisomerases’ inhibitors and has published more than 60 papers in this field.
- He is developing basic and translational research programs to identify alternative therapies for the treatment of castration-resistant prostate cancers.
Considering JDRR for your work?
This journal is guided by Philippe Pourquier (INSERM U1194, Montpellier Cancer Research Institute, France) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.